section name header
References
Organ Transplant Recipient in Primary Health Care - Related Resources
Cochrane reviews
Antiviral therapy
for recurrent
liver
graft infection with
hepatitis C
virus might possibly be of no clinical
benefit
, but there is insufficient evidence from adequate trials
Antiviral Therapy for Recurrent Liver Graft Infection with Hepatitis C Virus
.
Pre-emptive treatment
with
antiviral agents
for solid organ transplant recipients reduces the
risk
of cytomegalovirus
disease
when compared to
placebo
or standard care. The outcomes are similar to routine prophylactic antiviral therapy. There is insufficient evidence of the
efficacy
of pre-emptive therapy compared with
prophylaxis
to prevent CMV disease
Pre-Emptive Antiviral Treatment to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients
.
Prophylaxis with
immunoglobulin G
(IgG), anti CMV
vaccine
or
interferon
appear not to significantly reduce CMV disease and CMV-associated
mortality
in solid organ transplant recipients
Immunoglobulins, Vaccines or Interferon for Preventing Cytomegalovirus Disease in Solid Organ Transplant Recipients
.
Fish oil
appears not to improve clinical outcomes in
kidney
transplant recipients
Fish Oil for Kidney Transplant Recipients
.
Interleukin 2 receptor antagonists
for prophylaxis against
acute rejection
in kidney transplant recipients are
as
effective as
other
antibody therapies and with significantly fewer
side effects
, but there is no definite improvement in graft or patient
survival
Interleukin 2 Receptor Antagonists for Kidney Transplant Recipients
.
Calcium channel blockers
given in the peri-operative period appear to reduce the
incidence
of acute tubular
necrosis
in kidney transplant recipients .
Treatment with a bisphosphonate,
vitamin D
sterol or calcitonin after
kidney transplantation
may protect against
immunosuppression
-induced reductions in
bone
mineral density and prevent
fracture
Prevention of Bone Disease in Kidney Transplant Recipients
.
Other evidence summaries
Transplantation may result in improvement of the
quality of life
in the majority of
patients
Transplantation and Quality of Life
.
Steroid
withdrawal
in renal transplant patients on
triple therapy
with a calcineurin inhibitor and
mycophenolate mofetil
results a low but significant risk of acute rejection, but may not increase the risk of early graft failure .
Primary/Secondary Keywords
Related resources